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Introduction
Tumours of the breast are believed to arise from terminal
ductal lobular units and comprise two common morpho-
logical types: ductal and lobular neoplasia [1]. Rarer
morphological types include tubuloductal, comedo,
medullary, mucinous and Paget types [2]. Morphological
type has implications for treatment and prognosis, and it
would be of interest to determine whether morphological
type is genetically determined.
Breast tumours often present with mixed morphological
types, suggesting that in such cases a single genetic
background can give rise to tumours of multiple morpholo-
gies. It is also known that lobular in situ cancers may give
ICD = International Classification of Diseases.
Available online http://breast-cancer-research.com/content/4/4/R7
Abstract
Background: We conducted the present study to determine whether breast cancer morphology is
genetically determined.
Methods: Using the nationwide Swedish Family Cancer Database, which includes data on 10.2 million
individuals and over 25,000 morphology-specific breast cancers, we followed morphological types in
familial cancers between mothers and daughters and between sisters. Additionally, we recorded
morphological data in women who presented with two primary breast cancers and in those who
presented with an invasive and in situ breast cancer. We used kappa statistics to examine the
association between genetics and morphology. A kappa value of 0 indicates that the process is
random and a value of 1 indicates that it is completely determined (i.e. genetic); values between 0.40
and 0.60 are considered to indicate a moderately determined process.
Results: The study sample included a total of 25,730 first and 3394 second invasive breast cancers,
and 2990 in situ breast cancers. Ductal, lobular, tubuloductal and comedo were the most common
invasive types. We identified 164 mother–daughter pairs with breast cancer of a defined morphology,
yielding a low kappa value of 0.08. Among 100 sister pairs the kappa value was 0.002. In individuals
with two primary breast cancers the kappa values were 0.22 and 0.01 for two invasive and in situ-
invasive pairs, respectively. However, for a tumour with a subsequent tumour detected in the
contralateral breast less than 1 year later the kappa value was 0.47.
Conclusion: The data suggest that breast cancer morphology is not genetically determined. However,
because of mixed morphologies and the overwhelming prevalence of ductal morphology, the results for
rare morphologies should be interpreted with caution.
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rise to ductal invasive cancers [2,3]. Very limited data are
available on morphological types in familial and heritable
breast cancer. The only consistent morphological features
in breast cancers associated with mutations in the BRCA1
and  BRCA2 genes are the lower frequencies of lobular
morphology as compared with the frequencies in
BRCA1/2-unrelated familial breast cancers [4,5]. BRCA1-
related tumours exhibit a small excess of medullary-like
morphology. BRCA1/2-related breast cancers also tend to
have ductal or lobular in situ histology less frequently than
do all breast cancers combined [5]. Familial breast cancers
that are unrelated to BRCA1/2 have not shown any signifi-
cant morphological difference from all breast cancers com-
bined [4]. On the basis of earlier small studies, it was
assumed that mutations in the E-cadherin gene are only
present in lobular breast cancer; this was not confirmed in
a recent larger study, however, which identified mutations
in the E-cadherin gene in ductal cancer also [6].
In the present study we used the nationwide Swedish
Family Cancer Database to examine the morphological
types of breast cancer in family members and in individu-
als with two primary tumours [7]. The Database was
updated in 2001 to include over 10 million individuals and
over 1 million registered tumours, retrieved from the
Swedish Cancer Registry for the years 1958–1998. It
offers unique possibilities for reliable estimation of familial
risk because the data on familial relations and cancers
were obtained from registered sources with practically
complete coverage. The Swedish Cancer Registry has
used the International Classification of Diseases (ICD)
coding system ICD-O-2 since 1993. Thus, the specific
morphological classification covers only 6 years, but
because of its nationwide coverage a large number of
breast cancer patients are included.
We conducted the present study in order to determine
whether morphological type defines a discrete genetic
background.
Patients and methods
The Swedish Family Cancer Database was initially created
during the mid 1990s by linking an administrative family
register on all Swedish families to the Swedish Cancer
Registry [7–9]. For each child there are data on both
parents at the time of birth. Each person has been
assigned a unique identification number (which is different
from the national identification number – the ‘personal
number’); this allows construction of families, for example,
through the mother. The Database includes data for all
persons born in Sweden after 1931, along with data for
their biological parents, totalling over 10.2 million individu-
als. It was updated at the start of the year 2001 to include
cancers from the nationwide Swedish Cancer Registry for
the years 1958–1998. The Database is organized into
3.2 million families (parents and offspring).
The completeness of cancer registration during the
1970s has been estimated at over 95%, and is now
considered to be close to 100%. The percentage of
cytologically or histologically verified breast cancer
cases is close to 100% [10]. The Swedish Family
Cancer Database has incomplete linkage from
deceased offspring to parents, particularly among those
born between 1932 and 1940. Out of a total of 7.0
million offspring, 216,000 had died by the end of follow
up (31 December 1998). Parental information was
missing for 15,000 deceased offspring who had a diag-
nosis of cancer (9.9% of all cancers in offspring). This
deficit is unlikely to have any significant impact on the
findings of the present study.
The Swedish Cancer Registry is based on compulsory
notification of cases [10]. A four-digit diagnostic code, in
accordance with the 7th revision of the ICD, was used
until the year 1992; thereafter, the ICD-O-2 coding system
was employed. In cases of multiple morphological types,
the notifications considered the most common morphol-
ogy. Among first and second breast cancers, and in situ
and invasive cancers, all cases were included; however,
the analysis considered whether second cancers occurred
in the same breast or in the contralateral one, and the time
interval between diagnoses.
Family history information was collected for all first-degree
relatives (parents, siblings and children), but only
mother–daughter and sister–sister relationships were con-
sidered in the present study. In a small number of families
three or more sisters were affected, but they were not
included in the present analysis.
Statistical analysis was based on kappa statistics as a
measure of agreement between morphologies; kappa
values are calculated using the following equation [11,12].
observed number of cases – expected number of cases
Kappa = (1)
1 – expected number of cases
Kappa can take values between –1 and 1; 0 indicates
complete chance occurrence, and –1 or 1 indicates a
process that is completely determined. Values between
0.40 and 0.60 are considered moderately determined.
For simplicity, in the present report we present only posi-
tive values of kappa by deleting the minus sign. The
kappa values are unweighted, but all findings were also
tested using the weighted kappa test, with unaltered
results [11]. Some tests were also done on selected
morphological types.
Use of the Swedish Family Cancer Database was
approved by the Ethics Committee of the Karolinska Insti-
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Results
The Swedish Family Cancer Database covers the years
1958–1998 from the Swedish Cancer Registry, but
because specific morphology has been recorded since
1993 we included only those breast cancers that were
diagnosed between 1993 and 1998. Familial breast
cancer was defined as those cases in which breast cancer
was diagnosed in a mother or sister of the index patient
during the period from 1993 to 1998.
The numbers of morphology-specific breast cancers are
shown in Table 1. A total of 25,730 first and 3394 second
invasive breast cancers, and 2990 in situ breast cancers
were recorded during the 6-year period from 1993 to
1998 in Sweden. Ductal and lobular invasive, and in situ
cancers were the most common forms; the group ‘other’
mainly included undefined morphological types, termed
‘adenocarcinoma’. For in situ cancers some morphologies,
such as tubuloductal, mucinous, medullary and cystosar-
coma phyllodes, were not used. The comedo type was rel-
atively more frequent among in situ (15.1%) than among
invasive cases (5.6%).
Table 2 shows the distribution of morphology-specific
breast cancers between mothers and daughters, diag-
nosed during the years 1993–1998. Only the three most
common morphological types are shown separately. A
total of 164 mother–daughter pairs were analyzed and a
kappa value of 0.08 was calculated, indicating that the
morphologies of familial cancers between two generations
were entirely random. A similar analysis was carried out
between sisters, amounting to 100 pairs (Table 3). The
kappa value was 0.002, indicating that the morphology
between sisters was also entirely random.
Multiple primary breast cancers were also considered
(Table 4). In 907 women, two primary cancers were diag-
nosed. The overall kappa value was still low, at 0.22, but
there were some types that appeared to be less random.
Among 147 women with first lobular cancers, 55 pre-
sented with a second lobular cancer. However, the kappa
value was almost equal, at 0.23, when only ductal and
lobular morphologies were tested. Similarly, among 66
tubuloductal first cancers, 14 women were subsequently
diagnosed as having a second tubuloductal cancer. The
relationships between in situ and invasive breast cancer
Available online http://breast-cancer-research.com/content/4/4/R7
Table 1
Number of morphology-specific breast cancers in the Swedish Family Cancer Database during the period 1993–1998
1st invasive 2nd invasive In situ
Morphology n % n % n %
Ductal 14,187 66.2 1679 60.9 1834 69.9
Lobular 2936 13.7 531 19.2 324 12.4
Tubuloductal/tubular 1915 8.9 232 8.4 2 0.1
Comedo 1190 5.6 133 4.8 397 15.1
Mucinous 608 2.8 87 3.2 0 0.0
Medullary 340 1.6 29 1.1 0 0.0
Papillary 117 0.5 24 0.9 55 2.1
Morbus Paget 100 0.5 43 1.6 11 0.4
Cystosarcoma phyllodes 47 0.2 1 0.0 0 0.0
Other 4290 635 367
All 25,730 3394 2990
Percentages are for all cancers apart from those in the ‘Other’ category (undefined morphological types). Thus, for first primary the percentages
provided are from a total of 21,440 cancers, for second primary they are from a total of 2759 cancers, and for in situ they are from a total of 2623
cancers.
Table 2
Numbers of familial breast cancers in mother and daughter by
morphology
Mother
Daughter Ductal Lobular Tubuloductal Other All
Ductal 52 8 6 36 102
Lobular 8 2 0 7 17
Tubuloductal 11 0 1 1 13
Other 20 4 2 6 32
All 91 14 9 50 164
Kappa value for all types 0.08.among 465 women are shown in Table 5. The overall
kappa value was low, at 0.01, but some combinations of in
situ and invasive cancers (i.e. comedo with ductal, and
lobular with tubuloductal) appeared commonly.
In Tables 4 and 5 all first and second cancers are consid-
ered irrespective of laterality or timing between the two.
These variables influenced kappa values (Table 6). For the
first/second invasive cancer sequence, kappa values
increased when the second cancer was diagnosed in the
contralateral breast (from 0.22 to 0.38) and marginally
when it was diagnosed less than 1 year from identification
of the first cancer (0.23). When both of these conditions
were met, the kappa value was 0.47, indicating moderate
dependence between the morphologies. With these con-
ditions, the kappa value was 0.63 when only ductal and
lobular types were tested. The reason for these increased
kappa values was that lobular tumour was often followed
by another lobular tumour. Kappa was 0.40 even when
ductal and lobular types were tested separately for con-
tralateral breast cancers diagnosed more that 1 year apart.
Similarly, in the in situ/invasive sequence, the kappa value
was 0.33 when contralateral breasts were affected within
1 year. All of the kappa values were lower in the in
situ/invasive sequence than in the first/second breast
cancer sequence.
Discussion
We used the kappa test in the present analysis to test
whether the morphologies of two breast cancers in family
members or within the same individuals were of similar or
different types [11,12]. A word of caution is in order here
because the test considers the numbers of events, and
common types of events are weighted more than are rare
events. The ductal type, being the dominant morphology,
may overshadow the patterns of rare types. Moreover,
breast cancer is often of mixed morphology at presenta-
tion [3], and only the main type was recorded in the
Swedish Cancer Registry. The problem of dominance can
be avoided by testing individual rare types separately, but
for small numbers of cases the random variation may be
large. Thus, the familial cancers were so few in the present
study that it was not meaningful to test separately the pat-
terns for rare morphologies.
The data used in the present analysis were taken from the
Swedish Family Cancer Database, which has almost com-
plete nationwide coverage of families and cancer cases
[7–9]. Although morphological classification has been
used for only 6 years (from 1993 to 1998), the database
includes information on over 25,000 first invasive and
almost 3000 in situ cases.
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Table 3
Numbers of familial breast cancers in sisters by morphology
Sister 2
Sister 1 Ductal Lobular Tubuloductal Other All
Ductal 39 8 4 7 58
Lobular 6 2 1 4 13
Tubuloductal 11 1 0 1 13
Other 10 3 1 2 16
All 66 14 6 14 100
Kappa value for all types 0.002.
Table 4
Numbers of breast cancers in women with first and second invasive breast cancer by morphology
2nd invasive
1st invasive Ductal Lobular Tubuloductal Comedo Medullary Mucinous Mb Paget Papillary Other  All
Ductal 224 77 36 14 3 8 18 2 51 433
Lobular 56 55 23 3 0 0109 1 4 7
Tubuloductal 25 17 14 2 0 2015 6 6
C o m e d o 1 3 53 1 2 01807 4 9
Medullary 4 1 0 5 0 1001 1 2
Mucinous 11 3 4 0 0 5002 2 5
Morbus Paget 5 2 0 1 1 0001 1 0
Papillary 3 0 2 0 0 10006
Other 51 12 9 1 0 2 0 0 84 159
All 392 172 91 38 4 20 27 3 160 907
Kappa value for all types 0.22; kappa value for ductal and lobular 0.23; kappa value for ductal, lobular and tubuloductal 0.18.The main finding of the present study is that the morpho-
logical types of breast cancer are not genetically deter-
mined. The kappa values were close to 0 for
morphology-specific familial breast cancers, analyzed in
mother–daughter or sister–sister pairs. Such analyses are
most convincing because the presentation of morphology
is completely independent. Even the morphological pre-
sentation of first and second breast cancers, and in situ
and invasive breast cancers were almost completely
random when restricted to contralateral cancers diag-
nosed more than 1 year apart. Such conditions are likely
to define two independent primary tumours. The only
exception was when ductal and lobular cancers were
tested separately, for which the kappa value was 0.40.
The only observations that suggest a nonrandom presen-
tation were confined to contralateral invasive tumours,
diagnosed less than 1 year apart. The kappa value was
Available online http://breast-cancer-research.com/content/4/4/R7
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Table 5
Numbers of breast cancers in women with invasive and in situ breast cancer by morphology
Invasive
In situ Ductal Lobular Tubuloductal Comedo Medullary Mucinous Morbus Paget Papillary Other  All
Ductal 77 37 44 7 2 15 9 3 13 207
Lobular 63 12 37 12 1 1 2 0 6 134
Tubular 0 0 0 0 0 0 0 0 1 1
Comedo 45 7 11 4 1 4 5 0 2 79
Morbus Paget 2 0 0 1 0 0 0 0 0 3
Papillary 4 1 2 0 0 0 0 0 0 7
Other 13 1 2 1 0 0 0 0 17 34
All 204 58 96 25 4 20 16 3 39 465
Kappa value for all types 0.01; kappa value for ductal and lobular 0.18; kappa value for ductal, lobular and tubuloductal 0.08.
Table 6
Kappa measures of agreement
Kappa
Ductal and  Ductal, lobular and 
Condition n All types lobular tubuloductal
1st/2nd invasive
Include all 907 0.22 0.23 0.18
Contralateral breast 653 0.38 0.56 0.47
<1 year interval 643 0.23 0.19 0.16
≥1 year interval 264 0.17 0.30 0.24
Contralateral breast and <1 year interval 416 0.47 0.63 0.54
Contralateral breast and ≥1 year interval 237 0.20 0.40 0.32
In situ/invasive
Include all 465 0.01 0.18 0.08
Contralateral breast 153 0.21 0.21 0.17
<1 year interval 359 0.06 0.28 0.14
≥1 year interval 106 0.15 0.25 0.22
Contralateral breast and <1 year interval 93 0.33 0.27 0.21
Contralateral breast and ≥1 year interval 60 0.02 0.13 0.120.47 when all tumour types were tested and 0.63 when
testing was confined to ductal and lobular types. These
high kappa values were accounted for by lobular tumours.
Lobular in situ or invasive breast cancer is often multifocal
or bilateral at presentation, and even if unilateral this mor-
phology has a tendency to predispose to cancer in the
contralateral breast [3,13]. The high kappa values for
tumours diagnosed less than 1 year apart suggest that the
second cancer is not independent from the first one, and
that it may be a recurring tumour. It may seem paradoxical
that an increased kappa was found only for contralateral
tumours diagnosed less than 1 year apart. The probable
explanation lies in the instructions in the Swedish Cancer
Registry regarding the reporting of multiple primary
tumours. Tumours that are diagnosed temporally close
together are likely to be reported as independent primaries
if they occur contralaterally rather than ipsilaterally.
Because practically all tumours reported to the Swedish
Cancer Registry are histologically or cytologically verified,
the reliability of the data is high, and this also applies to
second primaries [14].
In summary, within the limits of the present sample size,
the results suggest that morphological types of breast
cancer are not genetically determined.
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